Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02211235 · ClinicalTrials.gov registry record
Glycemic Monitoring in Cystic Fibrosis
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 146
- Enrollment target
NCT02211235 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 146 participants.
The verdict
NCT02211235 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 146 participants
- Enrollment target
Study Summary
Current guidelines on the diagnoses and management of cystic fibrosis (CF) related diabetes recommend treatment for diabetes based on diagnostic criteria derived from adults with type 2 diabetes. Increasing evidence supports treating early glucose abnormalities in cystic fibrosis patients to target CF specific outcomes, including lung function and nutrition (BMI-Body Mass Index). However, the criteria and timing of when to start insulin therapy in the 'prediabetic' state are unclear. A more accurate characterization of blood sugar variability in youth with and without CF will help the investigators better interpret continuous glucose monitor (CGM) findings in patients with CF prediabetes and diabetes and more accurately identify those individuals at greatest risk for disease progression.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2014-08 |
| Est. Completion | 2018-05-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02211235
The ClinicalTrials.gov registry entry for NCT02211235 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02211235 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02211235 about?
NCT02211235 is a clinical study titled "Glycemic Monitoring in Cystic Fibrosis". Current guidelines on the diagnoses and management of cystic fibrosis (CF) related diabetes recommend treatment for diabetes based on diagnostic criteria derived from adults with type 2 diabetes. Increasing evidence supports treating early glucose abnormalities in cystic fibrosis patients to target ...
What is the current status of trial NCT02211235?
This trial is currently completed. The enrollment target is 146 participants. The study started on 2014-08. Estimated completion is 2018-05-16.
Who is sponsoring clinical trial NCT02211235?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.